Clinical Trial Update: Safety and Effectiveness of Adding Either an HIV Vaccine, Interleukin-2, or Both to a Patient's Anti-HIV Drug Combination [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and effectiveness of adding an HIV vaccine, interleukin-2, or both to a patient's antiretroviral therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED